{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:10:41Z","timestamp":1788307841954,"version":"build-2803163510"},"reference-count":24,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>In August 2022, Italy launched a vaccination campaign to combat the spread of the monkeypox virus, which the WHO has designated as a public health emergency. Priority targets for the campaign included laboratory personnel and men who have sex with men with specific risk criteria. Primary immunization involved two doses of the Imvanex\/Jynneos vaccine, followed by a single booster dose. We conducted a study in two Italian towns, Bologna and Forl\u00ec, in October and November 2022 to investigate adverse events following immunization (AEFIs) of the monkeypox vaccine through participant-based active surveillance. Participants who received the vaccine and were aged 18 and over were invited to complete an e-questionnaire by scanning a QR code during their second vaccine appointment or by email one month after the booster dose. A descriptive analysis of AEFI incidences was conducted, with the results stratified by type and severity of symptoms. A total of 135 first-dose, 50 second-dose, and 6 single-dose recipients were included, with a mean age of 36.4 \u00b1 8.7 years. Systemic reactions after the first and second doses were reported by 39.3% and 26.0% of participants, respectively, with asthenia being the most common symptom. Local site reactions were reported by 97.0% and 100.0% of participants, respectively, with redness, swelling, and itching being the most common local AEFIs. Grade 3 or 4 AEFIs were reported for local AEFIs only by 16.8% and 14.0% of participants after the first and second doses, respectively. Our findings suggest that the monkeypox vaccine has a high tolerability profile in terms of short-term common systemic AEFIs. However, the high incidence and severity of local AEFIs highlight the need to monitor their persistence following intradermal administration of the vaccine.<\/jats:p>","DOI":"10.3390\/vaccines11071163","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:25:21Z","timestamp":1687911921000},"page":"1163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Safety of Monkeypox Vaccine Using Active Surveillance, Two-Center Observational Study in Italy"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-0277","authenticated-orcid":false,"given":"Marco","family":"Montalti","sequence":"first","affiliation":[{"name":"Unit of Hygiene, Department of Biomedical and Neuromotor Sciences, Public Health and Medical Statistics, University of Bologna, Via San Giacomo 12, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-5699","authenticated-orcid":false,"given":"Zeno","family":"Di Valerio","sequence":"additional","affiliation":[{"name":"Unit of Hygiene, Department of Biomedical and Neuromotor Sciences, Public Health and Medical Statistics, University of Bologna, Via San Giacomo 12, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Angelini","sequence":"additional","affiliation":[{"name":"Department of Public Health, Romagna Local Health Authority, Via della Rocca 19, 47121 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bovolenta","sequence":"additional","affiliation":[{"name":"Department of Public Health, Bologna Local Health Authority, Via Gramsci 12, 40121 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Castellazzi","sequence":"additional","affiliation":[{"name":"Department of Public Health, Romagna Local Health Authority, Via della Rocca 19, 47121 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cleva","sequence":"additional","affiliation":[{"name":"Unit of Hygiene, Department of Biomedical and Neuromotor Sciences, Public Health and Medical Statistics, University of Bologna, Via San Giacomo 12, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pandolfi","sequence":"additional","affiliation":[{"name":"Department of Public Health, Bologna Local Health Authority, Via Gramsci 12, 40121 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Reali","sequence":"additional","affiliation":[{"name":"Department of Public Health, Romagna Local Health Authority, Via della Rocca 19, 47121 Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Resi","sequence":"additional","affiliation":[{"name":"Department of Public Health, Bologna Local Health Authority, Via Gramsci 12, 40121 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Todeschini","sequence":"additional","affiliation":[{"name":"Department of Public Health, Bologna Local Health Authority, Via Gramsci 12, 40121 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4954-9419","authenticated-orcid":false,"given":"Davide","family":"Gori","sequence":"additional","affiliation":[{"name":"Unit of Hygiene, Department of Biomedical and Neuromotor Sciences, Public Health and Medical Statistics, University of Bologna, Via San Giacomo 12, 40126 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"ref_1","unstructured":"WHO\u2013World Health Organization (2023, May 05). Monkeypox. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tiecco, G., Degli Antoni, M., Storti, S., Tomasoni, L.R., Castelli, F., and Quiros-Roldan, E. (2022). Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?. Viruses, 14.","DOI":"10.3390\/v14091894"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1080\/22221751.2022.2095309","article-title":"Monkeypox virus emerges from the shadow of its more infamous cousin: Family biology matters","volume":"11","author":"Xiang","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Riopelle, J.C., Munster, V.J., and Port, J.R. (2022). Atypical and Unique Transmission of Monkeypox Virus during the 2022 Outbreak: An Overview of the Current State of Knowledge. Viruses, 14.","DOI":"10.20944\/preprints202208.0128.v1"},{"key":"ref_5","unstructured":"WHO (2023, May 05). WHO Director-General\u2019s Statement at the Press Conference following the IHR Emergency Committee Regarding the Multi-country Outbreak of Monkeypox\u201423 July 2022. Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022."},{"key":"ref_6","unstructured":"(2023, May 05). Epidemia di Vaiolo delle Scimmie in Paesi Non Endemici, Maggio 2022. Istituto Superiore di Sanit\u00e0, Epicentro\u2013L\u2019epidemiologia per la Sanit\u00e0 Pubblica. Available online: https:\/\/www.epicentro.iss.it\/monkeypox\/epidemia-2022."},{"key":"ref_7","unstructured":"(2023, May 05). Communicable Disease Threats Report, 24\u201330 July, Week 30. ECDC. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/communicable-disease-threats-report-24-30-july-week-30."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gomez-Lucia, E. (2022). Monkeypox: Some Keys to Understand This Emerging Disease. Animals, 12.","DOI":"10.3390\/ani12172190"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Beer, E.M., and Rao, V.B. (2019). A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007791"},{"key":"ref_10","unstructured":"WHO\u2013World Health Organization (2023, May 05). 2022 Mpox (Monkeypox) Outbreak: Global Trends. Available online: https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/."},{"key":"ref_11","unstructured":"Ministero della Salute (2023, May 05). Vaiolo delle Scimmie\u2013Mpox. Bollettino Nazionale, Available online: https:\/\/www.salute.gov.it\/portale\/vaioloScimmie\/dettaglioContenutiVaioloScimmie.jsp?lingua=italiano&id=5943&area=vaioloScimmie&menu=vuoto."},{"key":"ref_12","unstructured":"Ministero della Salute (2023, May 05). Circolare 2 Agosto 2022, Available online: https:\/\/www.trovanorme.salute.gov.it\/norme\/renderNormsanPdf?anno=2022&codLeg=88439&parte=1%20&serie=null."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(22)00574-6","article-title":"Prevention of monkeypox with vaccines: A rapid review","volume":"22","author":"Poland","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","unstructured":"Ministero della Salute (2023, May 05). Circolare 5 Agosto 2022\u2013Indicazioni ad Interim sulla Strategia Vaccinale Contro il Vaiolo delle Scimmie (MPX), Available online: https:\/\/www.trovanorme.salute.gov.it\/norme\/renderNormsanPdf?anno=2022&codLeg=88498&parte=1%20&serie=null."},{"key":"ref_15","unstructured":"FDA\u2013Food and Drug Administration (2023, May 05). Package Insert\u2013JYNNEOS, Available online: https:\/\/www.fda.gov\/media\/131078\/download."},{"key":"ref_16","unstructured":"IOMS\/WHO Working Group on Vaccine Pharmacovigilance (2012). Definition and Application of Terms for Vaccine Pharmacovigilance: Report of Cioms\/Who Working Group on Vaccine Pharmacovigilance, World Health Organization."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/cid\/ciz1034","article-title":"Comparative immunogenicity of several enhanced influenza vaccine options for older adults: A randomized, controlled trial","volume":"71","author":"Cowling","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 MRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the MRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Quach, H.Q., and Kennedy, R.B. (2022). Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis. Viruses, 14.","DOI":"10.3390\/v14112438"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"122559","DOI":"10.1016\/j.ijpharm.2022.122559","article-title":"Emerging adjuvants for intradermal vaccination","volume":"632","author":"Chen","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.15585\/mmwr.mm7149a4","article-title":"Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak\u2013United States, 22 May\u201321 October 2022","volume":"71","author":"Duffy","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.vaccine.2022.10.056","article-title":"A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN\u00ae vaccine in healthy adults","volume":"41","author":"Schmidt","year":"2023","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1001\/jama.2023.7683","article-title":"Short-term Adverse Events Following Immunization with Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox","volume":"329","author":"Deng","year":"2023","journal-title":"JAMA"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/7\/1163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:01:37Z","timestamp":1760126497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/7\/1163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["vaccines11071163"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11071163","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]}}}